Real-time enrollment status for this large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 8:06 PM UTC
| NCT Number | NCT06500273 |
| Recruiting Status | Recruiting |
| Condition | Large B-cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 250 participants |
| Active Locations | 62 sites in the US |
| Sponsor | Allogene Therapeutics |
| Last Updated on CT.gov | August 31, 2026 (20 hours ago) |
As of August 31, 2026: Clinical trial NCT06500273 is currently recruiting participants. This phase2 study for large b-cell lymphoma is actively seeking new participants at 62 locations across the United States. The study is sponsored by Allogene Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06500273 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 62 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06500273 was last updated 20 hours ago (August 31, 2026). HelloStudys verifies this status automatically.